跳至主要内容
临床试验/NCT04619511
NCT04619511已完成不适用

Risk Factors for Post-ESWL and Post-ERCP Pancreatitis in Patients With Chronic Pancreatitis

Changhai Hospital0 个研究点目标入组 714 人开始时间: 2016年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
714
主要终点
post endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis

研究概览

简要总结

The study aimed to identify risk factors for post-ERCP pancreatitis(PEP) after ESWL, and the relationship between the occurrence of post-ESWL pancreatitis and PEP.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with chronic pancreatitis and treated with both ESWL and subsequent ERCP

排除标准

  • Patients with isolated pancreatic tail stone
  • Patients with suspected or established malignancy
  • Patients with pancreatic ascites
  • Patients attending other interventional clinical trials
  • Patients with non-correctable coagulation disorder
  • Patients with pregnancy

结局指标

主要结局

post endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis

时间窗: up to 1 months

The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.

post pancreatic extracorporeal shock wave lithotripsy (ESWL) pancreatitis

时间窗: up to 1 months

The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhuan Liao

Principal Investigator

Changhai Hospital

相似试验